Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Viaca (Sildenafil + Cabergoline) in Healthy Volunteers
NCT07732387Phase 1Not yet recruiting
- Start
- Aug 2026
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Phase 1, open-label trial in erectile dysfunction (ED) (5 cohorts). Primary endpoints: Adverse Events and Serious Adverse Events, Blood pressure and 7 more. Planned start Aug 2026; status: not yet recruiting.
02
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT07732387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07732387.